CIK 0001341235 · Non-accelerated filer<br>Smaller reporting company
Aldeyra Therapeutics, Inc.
Sign in to watch- Ticker
- ALDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 781-761-4904
- Business address
- 23 BRADFORD STREET, SUITE 1, CONCORD, MA, 01742
- Former names
- Aldexa Therapeutics, Inc., Neuron Systems Inc
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale 10% owner sold 3,400,000 shares at $1.42 ($4,828,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 922 shares at an average $11.33 ($10,447)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Development Officer sold 16,041 shares at $4.74 ($75,975)
- 4 Open-market sale See Remarks sold 10,834 shares at $4.74 ($51,313)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Open-market sale Chief Development Officer sold 11,537 shares at $3.16 ($36,503)
- 4/A Open-market sale See Remarks sold 13,201 shares at $3.41 ($44,968)
- 4 Open-market buy 10% owner bought 177,993 shares at an average $4.68 ($833,867)
- 4 Open-market buy 10% owner bought 504,272 shares at an average $3.84 ($1,934,505)
- 4 Open-market sale See Remarks sold 13,201 shares at $3.41 ($44,968)
Page 2 of 12 · 221 filings